← All candidates
167 insider filings on record.
167 filings on record.
CBLLCeribell, Inc.
NasdaqGS · Healthcare · $956.57M
$24.33
+2.96% · Sep 14
167 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 71 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$956.57M
Float
26.5M
69% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
9.4
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
162 more transactions on Pro →Context
Wall St
$26.86 avg target
+10.4% vs today · 7 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26−$0.38 act+$0.01
Q4 '25−$0.36 act+$0.05
Q3 '25−$0.37 act+$0.04
Q2 '25−$0.38 act+$0.02
Coverage
Is CeriBell, Inc. (CBLL) Among the Best Brain-Computer Interface Stocks to Buy?Insider Monkey · 06-27CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit RecordsMarketBeat · 05-15CeriBell Inc (CBLL) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Market ...GuruFocus.com · 05-12CeriBell Q1 Earnings Call HighlightsMarketBeat · 05-11
The file stays open
167 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice